Ashok Leyland Q1 FY27 Results Analysis: Margin Compresses 105 bps, Impairment Losses Jump 47.8% (ASHOKLEY)
Ashok Leyland Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 9,634.35 Cr (+10.43% YoY) and PAT growth of +2.59% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 14, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 9,634.35 Cr (+10.43% YoY) |
| PAT (Q1) | Rs. 609.11 Cr (+2.59% YoY) |
| EBITDA margin | 10.06% (-105 bps YoY) |
| EPS (Q1) | Rs. 1.04 (+2.97% YoY) |
| Market cap | Rs. 100,532.31 Cr |
| CMP | Rs. 171.90 |
Quarter Snapshot
Ashok Leyland reported record Q1 revenue and volumes in the CV segment, with MHCV and LCV both posting double-digit growth. However, standalone EBITDA margin compressed 105 bps YoY due to cost pressures, and the financial services segment saw a sharp 47.8% jump in impairment losses. Export volumes declined 18% YoY and the HLF merger listing was delayed, tempering the positive volume news.
Key Investment Insights
Key Positives
- Standalone revenue of Rs.9,634 Cr, highest ever Q1, growing 10.43% YoY
- Total CV volumes at 48,763 units, a Q1 record, with MHCV ex-Defence up 15% and LCV domestic up 21% YoY
- Standalone net cash position improved to Rs.2,252 Cr, near debt-free balance sheet (D/E 0.08x)
- No exceptional items in the quarter; normalized PAT equals reported PAT
- CV segment revenue grew 9.6% YoY driven by volume growth
Risk Factors
- Standalone EBITDA margin compressed 105 bps YoY to 10.06%, driven by cost pressure and flat EBITDA
- Consolidated impairment loss in financial services rose 47.8% YoY to Rs.471.96 Cr, compressing FS segment margin by 204 bps
- Export volumes declined 18.3% YoY to 2,461 units, missing the 20% CAGR trajectory
- HLF merger listing target for Q1 FY27 was missed; NCLT application filed only on June 1, 2026
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.